Malik RA, Anderson J, Russo G, Amani MEA, et al. Long-term effectiveness of iGlarLixi treatment in people with type 2 diabetes in the United States: The soli-durability 24-month observational study. Diabetes Obes Metab 2025 Aug 11. doi: 10.1111/dom.16591.
PMID: 40785322